Pharma USA 2023: Digital Therapeutics and Pharma

Article

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.

Recent Videos
Related Content
Kevin T. Foley, MD

True Digital Surgery Appoints Kevin T. Foley as Chief Medical Officer

September 23rd 2024
Articles

As chief medical officer, Foley is expected to guide the clinical direction of True Digital Surgery and the advancement of its Digital Surgical Exoscope Platform.

Syda Productions, stock.adobe.com

MedTech MVP 2023: Building the Digital Operating Room

July 20th 2023
Articles

Aside from robotics, modern ORs can benefit greatly by incorporating modern digital technologies.

Eko Health Core 500 digital stethoscope

Digital Stethoscope Utilizes AI Software and Digital Auscultation

June 28th 2023
Articles

Eko Health developed the device, which has received 501(k) clearance from the FDA.

Tracey Dodenhoff, CEO, Medly Therapeutics | Image Credit: from video

Pharma USA 2023: Getting Physician Buy-In for Digital Therapeutics

May 8th 2023
Articles

Taking the physician's workflow into account can pave the way for greater acceptance of digital therapeutics.

Scott Snyder

Q&A With Scott Snyder, Chief Digital Officer at Eversana

May 2nd 2023
Articles

Snyder discusses how digital tools are changing the ways that patients interact with doctors.

Pharma 2023: Digital Health Key Takeaways

Pharma 2023: Digital Health Key Takeaways

April 20th 2023
Articles

Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.

© 2024 MJH Life Sciences

All rights reserved.